Loading organization details...
Loading organization details...
Source: IRS Form 990 via ProPublica Nonprofit Explorer
Total Revenue
▼$630.5M
Total Contributions
$513.8M
Total Expenses
▼$646M
Total Assets
$1.5B
Total Liabilities
▼$672M
Net Assets
$797.3M
Officer Compensation
→$14.7M
Other Salaries
$282.9M
Investment Income
▼$13.3M
Fundraising
▼$660.8K
Source: USAspending.gov · Searched by organization name
VA/DoD Awards
$29.1M
VA/DoD Award Count
7
Funding from the Department of Veterans Affairs and/or Department of Defense.
Total Federal Funding (partial)
$1.3B
Awards Found
200+
Additional awards may exist. View all on USAspending.gov →
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Health and Human Services | LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIALS NETWORK | $102.1M | FY2006 | Jun 2006 – May 2013 |
| Department of Health and Human Services | LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; MICROBICIDE TRIALS NETWORK | $65.8M | FY2006 | Jun 2006 – Nov 2021 |
| Department of Health and Human Services | HVTN LABORATORY PROGRAM | $49.6M | FY2006 | Jun 2006 – May 2013 |
| Department of Health and Human Services | LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HIV VACCINE TRIALS NETWORK | $29.8M | FY2006 | Jun 2006 – May 2013 |
| Department of Health and Human Services | SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER | $28.8M | FY1985 | Jan 1985 – Feb 2015 |
| Department of Health and Human Services | ELICITING VRC01-LIKE BNABS BY SPECIFICALLY DESIGNED ENV IMMUNOGENS | $25.1M | FY2014 | Mar 2014 – Feb 2022 |
| Department of Health and Human Services | PERSONAL PROTECTIVE EQUIPMENT FOR RESOURCES FOR COVID-19 RELATED VACCINE AND TREATMENT CLINICAL TRIALS AND CLINICAL STUDIES | $23M | FY2020 | Aug 2020 – Mar 2022 |
| Department of Health and Human Services | BARRETT'S ESOPHAGUS: PREDICTORS OF PROGRESSION | $22M | FY2002 | Aug 2002 – Mar 2021 |
| Department of Health and Human Services | TARGETED MODIFICATION OF HOST AND PROVIRAL DNA TO TREAT LATENT HIV INFECTION | $20.8M | FY2011 | Jul 2011 – Jun 2017 |
| Department of Health and Human Services | LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HIV PREVENTION TRIALS NETWORK | $17.3M | FY2006 | Jun 2006 – May 2013 |
| Department of Health and Human Services | CANCER IMMUNOTHERAPY TRIALS NETWORK CENTRAL OPERATIONS AND STATISTICAL CENTER | $16.7M | FY2010 | Sep 2010 – Aug 2017 |
| Department of Health and Human Services | THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES | $15M | FY1997 | May 1997 – Jul 2017 |
| Department of Health and Human Services | PERSONAL PROTECTIVE EQUIPMENT FOR RESOURCES FOR COVID-19 RELATED VACCINE AND TREATMENT CLINICAL TRIALS AND CLINICAL STUDIES - PROJECT SUMMARY/ABSTRACT PLANNED COVID-19 VACCINE TRIALS REQUIRE SCREENING, ENROLLING, AND FOLLOWING OVER 150,000 VOLUNTEER STUDY PARTICIPANTS OVER 24 MONTHS. THE TRIAL PARTICIPANTS WILL BE SELECTED BASED ON THEIR RISK OF COVID-19 INFECTION, WITH TRIAL PARTICIPANTS COMING FROM SETTINGS WITH HIGH RATES OF COMMUNITY TRANSMISSION, GROUPS WITH HIGHER RISK OF PROGRESSION TO SYMPTOMATIC DISEASE, OR BOTH. STUDY STAFF WORKING ON COVID-19 VACCINE TRIALS WILL NEED TO INTERACT WITH TRIAL PARTICIPANTS DURING REGULAR VISITS AS WELL AS CONDUCTING IN-PERSON ASSESSMENTS OF ALL VACCINE TRIAL PARTICIPANTS WITH SYMPTOMS THAT COULD BE DUE TO COVID-19 DISEASE. THIS WILL RESULT IN CLOSE CONTACT BETWEEN STUDY STAFF AND HIGH-RISK PARTICIPANTS OR INFECTED PARTICIPANTS. AS A RESULT, STUDY STAFF NEED TO ACCESS A REGULAR SUPPLY OF PERSONAL PROTECTIVE EQUIPMENT (PPE), INCLUDING SURGICAL MASKS, FACE SHIELDS OR GOGGLES, GOWNS, AND DISPOSABLE GLOVES, AS WELL AS THE ABILITY TO SANITIZE HANDS FREQUENTLY. THIS COMBINATION OF PPE WILL BE USED DURING ALL RISKY INTERACTIONS WITH STUDY PARTICIPANTS, SUCH AS DURING NASAL SWAB COLLECTION AND DURING EVALUATION OF PARTICIPANTS FOR POSSIBLE STUDY ENDPOINTS, INCLUDING SYMPTOMATIC COVID-19 DISEASE. IN ADDITION, ALL STAFF WILL NEED TO WEAR SURGICAL FACE MASKS DURING AND THROUGHOUT THEIR NORMAL WORKDAY IN THE HEALTH CARE SETTING OR ON SITE FOR MOBILE STUDY SATELLITE SITES. WITHOUT APPROPRIATE PPE, HEALTH CARE WORKERS ARE VULNERABLE TO INFECTION WITH COVID-19, AS WELL AS PASSIVELY TRANSMITTING TO PERSONS WITH WHOM THEY ARE IN CLOSE PHYSICAL CONTACT. ACCESS TO ADEQUATE PPE IS A CRITICAL COMPONENT OF THE SAFE AND EFFECTIVE CONDUCT OF COVID-19 VACCINE TRIALS, AND WILL ENABLE ACCURATE DETERMINATION OF THE STUDY ENDPOINTS, ESPECIALLY SYMPTOMATIC COVID- 19 DISEASE. | $14.9M | FY2021 | Nov 2020 – Mar 2022 |
| Department of Health and Human Services | PACIFIC OVARIAN CANCER RESEARCH CONSORITUM | $14.6M | FY1999 | Sep 1999 – Jun 2017 |
| Department of Health and Human Services | MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS FOR SWEATS AND HOT FLASHES | $13.5M | FY2008 | Sep 2008 – Aug 2013 |
| Department of Health and Human Services | CENTER FOR STATISTICS AND QUANTITATIVE INFECTIOUS DISEASES | $12.5M | FY2014 | Sep 2014 – Jun 2020 |
| Department of Health and Human Services | DETECTION OF COLORECTAL CANCER SUSCEPTIBILITY LOCI USING GENOME-WIDE SEQUENCING | $12.4M | FY2012 | Sep 2012 – Aug 2017 |
| Department of Health and Human Services | NOTCH-MEDIATED EXPANSION OF CORD BLOOD PROGENITORS FOR STEM CELL TRANSPLANT | $12.4M | FY2012 | May 2012 – Apr 2020 |
| Department of Health and Human Services | THE PATHOGENESIS OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | $12.3M | FY2010 | Apr 2010 – Sep 2021 |
| Department of Health and Human Services | WOMEN'S HEALTH INITIATIVE CANCER SURVIVOR COHORT | $12.1M | FY2013 | Feb 2013 – Jan 2019 |
| Department of Health and Human Services | SEATTLE CANCER CONSORTIUM BREAST SPORE | $11M | FY2010 | Sep 2010 – Aug 2017 |
| Department of Health and Human Services | LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; MICROBICIDE TRIALS NETWORK | $10.1M | FY2006 | Jun 2006 – May 2013 |
| Department of Health and Human Services | TREC COORDINATION CENTER | $10M | FY2005 | Sep 2005 – May 2017 |
| Department of Health and Human Services | EPIDEMIOLOGY OF PUTATIVE GENUINE GENETIC VARIANT: THE WOMEN'S HEALTH INTIATIVE | $9.9M | FY2008 | Jul 2008 – May 2014 |
| Department of Health and Human Services | WHOLE GENOME ASSOCIATION ANALYSIS OF HEMATOPOIETIC CELL TRANSPLANT (HCT) OUTCOME | $9.8M | FY2011 | Jan 2011 – Jun 2021 |
| Department of Health and Human Services | RADIATION DOSE-DEPENDENT INTERVENTIONS | $9.7M | FY2005 | Aug 2005 – Jul 2011 |
| Department of Health and Human Services | UNDERSTANDING AND PREVENTING BREAST CANCER DISPARTIES IN LATINAS | $9.7M | FY2010 | May 2010 – Oct 2017 |
| Department of Health and Human Services | DATA CENTER CORE CONSOLIDATION | $9.6M | FY2010 | Mar 2010 – Oct 2012 |
| Department of Health and Human Services | HPV: BIOLOGY, CLINICAL SIGNIFICANCE AND EPIDEMIOLOGY | $9.1M | FY1997 | Jun 1997 – Jun 2012 |
| Department of Health and Human Services | MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN | $8.9M | FY2009 | Sep 2009 – Jun 2014 |
| Department of Health and Human Services | STEM CELL TRANSPLANTATION: BASIC/CLINICAL RESEARCH | $8.4M | FY1997 | Aug 1997 – Jul 2011 |
| Department of Health and Human Services | MOLECULAR ANALYSIS OF EUKARYOTIC TRANSCRIPTION | $8.4M | FY1995 | Sep 1995 – Apr 2021 |
| Department of Health and Human Services | EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WNT AND NOTCH | $8.4M | FY2009 | Sep 2009 – Apr 2017 |
| Department of Health and Human Services | CONTROLLING HEMATOPOIETIC LINEAGE COMMITMENT FROM ESC TO PLATELETS | $8.3M | FY2009 | Sep 2009 – Apr 2018 |
| Department of Health and Human Services | BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTIBILITY STUDY (BEAGESS) | $7.8M | FY2009 | Sep 2009 – Aug 2014 |
| Department of Health and Human Services | LATE EFFECTS OF TREATMENT IN WILMS TUMOR SURVIVORS AND OFFSPRING | $7.7M | FY1991 | Aug 1991 – Jul 2018 |
| Department of Health and Human Services | MOLECULAR CONTROL OF HEMATOPOIETIC STEM CELL FATE | $7.7M | FY2007 | May 2007 – Apr 2012 |
| Department of Health and Human Services | GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN COLON CANCER | $7.5M | FY1994 | Sep 1994 – May 2012 |
| Department of Health and Human Services | PROSPR STATISTICAL COORDINATING CENTER (PSCC) | $7.5M | FY2011 | Sep 2011 – Aug 2018 |
| Department of Health and Human Services | EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1 | $7.4M | FY1995 | Sep 1995 – Mar 2020 |
| Department of Health and Human Services | CORE CENTER OF EXCELLENCE IN HEMATOLOGY | $7.3M | FY1999 | Sep 1999 – Dec 2017 |
| Department of Health and Human Services | MSFLASH: LIVING A HEALTHY MENOPAUSE | $7.2M | FY2015 | Aug 2015 – Mar 2022 |
| Department of Health and Human Services | FUNCTION OF HUMAN & MOUSE BETA-GLOBIN LOCUS CONTROL REGIONS | $7.1M | FY1992 | Apr 1992 – Sep 2018 |
| Department of Health and Human Services | MAINTENANCE OF GENE EXPRESSION IN THE RED CELL LINEAGE | $7.1M | FY2000 | Sep 2000 – Aug 2019 |
| Department of Health and Human Services | THE COLON CANCER FAMILY REGISTRY: SEATTLE | $7M | FY1997 | Jul 1997 – Aug 2012 |
| Department of Health and Human Services | HIV TESTING AND TREATMENT TO PREVENT ONWARD HIV TRANSMISSION AMONG HIGH-RISK MSM | $6.6M | FY2011 | Jul 2011 – Apr 2018 |
| VA/DoDDepartment of Defense | IMPROVING OUTCOME FOR HEMORRHAGIC SHOCK USING INHIBITORS OF OXIDATIVE PHOSPHORYLATION | $6.6M | FY2006 | Jun 2006 – May 2010 |
| Department of Health and Human Services | MECHANISMS OF EUKARYOTIC TRANSCRIPTION ACTIVATION | $6.5M | FY2005 | Sep 2005 – Jun 2021 |
| Department of Health and Human Services | REGULATION OF CELL GROWTH AND PROLIFERATION BY MYC | $6.2M | FY1977 | Feb 1977 – Apr 2019 |
| Department of Health and Human Services | IMMUNOBIOLOGY OF TOLERANCE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATIO | $6.1M | FY1997 | Sep 1997 – Jul 2014 |
| Department of Health and Human Services | MECHANISMS AND FUNCTIONS OF ATP-DEPENDENT CHROMATIN REMODELING | $6M | FY1999 | Feb 1999 – Jul 2021 |
| Department of Health and Human Services | MOLECULAR ANALYSIS OF HOTSPOTS OF GENETIC RECOMBINATION | $5.9M | FY1982 | Jul 1982 – — |
| Department of Health and Human Services | CONTAINING BIOTERROIST AND EMERGING INFECTIOUS DISEASES | $5.9M | FY2004 | May 2004 – Dec 2014 |
| Department of Health and Human Services | A RANDOMZIED PHASE II TRIAL OF CMV PREVENTION IN ACUTE LUNG INJURY | $5.9M | FY2010 | Jun 2010 – Dec 2016 |
| Department of Health and Human Services | MONITORING THE DEVELOPMENT OF ANTI-ENV ABS DURING HIV INFECTION | $5.8M | FY2010 | Jan 2010 – Jan 2022 |
| Department of Health and Human Services | DISCOVERY AND VERIFICATION OF NOVEL BIOMARKERS OF COLORECTAL CANCER RECURRENCE | $5.5M | FY2015 | May 2015 – Mar 2022 |
| Department of Health and Human Services | TARGETED THERAPY OF ALL WITH GENE-MODIFIED CENTRAL MEMORY T CELLS | $5.5M | FY2009 | Jul 2009 – Aug 2019 |
| Department of Health and Human Services | THE ROLE OF UNCULTIVATED BACTERIA IN BACTERIAL VAGINOSIS | $5.5M | FY2006 | Jan 2006 – Nov 2017 |
| Department of Health and Human Services | PROACTIVE SMOKING CESSATION FOR ADOLESCENTS | $5.4M | FY2000 | Sep 2000 – Nov 2015 |
| Department of Health and Human Services | MODELING PROSTATE CANCER CONTROL: PREVENTION SCREENING TREATMENT FOLLOWUP CARE | $5.3M | FY2010 | Sep 2010 – Aug 2015 |
| Department of Health and Human Services | MODELING TO IMPROVE PROSTATE CANCER OUTCOMES ACROSS DIVERSE POPULATIONS | $5.2M | FY2015 | Sep 2015 – Aug 2021 |
| Department of Health and Human Services | MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION | $5.2M | FY2005 | Sep 2005 – Aug 2011 |
| Department of Health and Human Services | PCPT AND SELECT COHORTS: CORE INFRASTRUCTURE SUPPORT FOR CANCER RESEARCH | $5.1M | FY2013 | Sep 2013 – Jul 2019 |
| Department of Health and Human Services | HIV HOST-CELL INTERACTIONS | $5.1M | FY1991 | Aug 1991 – Mar 2022 |
| Department of Health and Human Services | STATISTICAL METHODS FOR MEDICAL STUDIES | $5M | FY1997 | Jan 1997 – Jun 2017 |
| Department of Health and Human Services | OBJECTIVE PHYSICAL ACTIVITY AND CARDIOVASCULAR HEALTH IN WOMEN AGED 80 AND OLDER | $4.9M | FY2011 | Sep 2011 – Apr 2017 |
| Department of Health and Human Services | MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN COMPLEX BIOLOGICAL SAMPLES | $4.8M | FY2009 | Sep 2009 – Aug 2011 |
| Department of Health and Human Services | INTERACTIONS OF HPV ONCOGENES WITH THE P53 PATHWAY | $4.8M | FY1995 | Dec 1994 – May 2018 |
| Department of Health and Human Services | EPIDEMIOLOGY OF THE FOUR MOST FREQUENT CANCERS FOLLOWING BREAST CANCER | $4.7M | FY2014 | Sep 2014 – Feb 2022 |
| VA/DoDDepartment of Defense | USE OF DEPO-MEDROXYPROGESTERONE ACETATE AND RISK OF PREMENOPAUSAL BREAST CANCER | $4.7M | FY2005 | Sep 2005 – Oct 2011 |
| Department of Health and Human Services | CENTER FOR HISPANIC HEALTH PROMOTION: REDUCING CANCER DISPARITIES | $4.7M | FY2010 | Sep 2010 – Aug 2016 |
| Department of Health and Human Services | ROLE OF THE PERIVASCULAR MICROENVIRONMENT IN PRIMARY AND METASTATIC BRAIN TUMORS | $4.6M | FY2011 | Sep 2011 – Jul 2016 |
| VA/DoDDepartment of Defense | ADVANCING OUR UNDERSTANDING OF THE ETIOLOGIES AND MUTATIONAL LANDSCAPES OF BASAL-LIKE, LUMINAL A, AND LUMINAL B BREAST CANCERS | $4.6M | FY2012 | Sep 2012 – Sep 2017 |
| Department of Health and Human Services | METHODS FOR EVALUATING VACCINE EFFICACY | $4.6M | FY1992 | Jan 1992 – Mar 2022 |
| Department of Health and Human Services | BREAST CANCER RISK AND MOLECULAR CHANGE AFTER CHERNOBYL | $4.6M | FY2007 | Sep 2007 – Jul 2013 |
| Department of Health and Human Services | EDRN:DATA MANAGEMENT AND COORDINATING CENTER | $4.5M | FY2000 | Apr 2000 – Jun 2010 |
| Department of Health and Human Services | TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION | $4.4M | FY2015 | Sep 2015 – Jul 2021 |
| Department of Health and Human Services | HPV CAPSID ANTIBODIES | $4.4M | FY1995 | May 1995 – Mar 2022 |
| Department of Health and Human Services | TRANSLATIONAL CONTROL OF CYTOMEGALOVIRUS GENE EXPRESSION | $4.3M | FY1988 | Aug 1988 – Sep 2018 |
| Department of Health and Human Services | PROFILING CANCER NEOANTIGEN REPERTOIRES AND VALIDATING IMMUNOTHERAPY TARGETS | $4.3M | FY2013 | May 2013 – Apr 2018 |
| Department of Health and Human Services | MYC ONCOPROTEIN FUNCTION | $4.2M | FY1991 | Sep 1991 – Dec 2013 |
| Department of Health and Human Services | PHYSICAL ACTIVITY TO IMPROVE CV HEALTH IN OLDER WOMEN: A PRAGMATIC TRIAL -- DCC | $4.2M | FY2015 | Feb 2015 – Jan 2021 |
| VA/DoDDepartment of Defense | TARGETING TUMOR DORMANCY TO PREVENT METASTATIC RELAPSE | $4.2M | FY2015 | Jul 2015 – Jun 2021 |
| Department of Health and Human Services | P3IK SIGNALING AND BIOLOGY OF THERAPEUTIC RESPONSE IN BRAIN AND PROSTATE TUMORS | $4.2M | FY2009 | Aug 2009 – Jul 2014 |
| Department of Health and Human Services | AN INTEGRATED COMPUTATIONAL AND FUNCTIONAL GENOMICS DISCOVERY ENGINE FOR PRECLINI | $4.1M | FY2013 | Jun 2013 – Apr 2018 |
| Department of Health and Human Services | DEFINING THE INFANT IMMUNE RESPONSE TO HIV | $4.1M | FY2016 | Jan 2016 – Dec 2021 |
| Department of Health and Human Services | BIOLOGIC DETERMINANTS OF THE NATURAL HISTORY OF AIDS-DEFINING CANCERS IN UGANDA | $4.1M | FY2014 | Sep 2014 – Aug 2020 |
| Department of Health and Human Services | TUMOR MAINTENANCE AND DEVELOPMENT IN MOUSE MODELS | $4M | FY2004 | Sep 2004 – Jul 2014 |
| Department of Health and Human Services | RNA AS A HORMONE: SYSTEMIC SIGNALING IN MAMMALS VIA CIRCULATING, CELL-FREE SMALL | $4M | FY2009 | Sep 2009 – Jan 2014 |
| VA/DoDDepartment of Defense | IMPROVING OUTCOME IN ISCHEMIA AND ISCHEMIA REPERFUSION INJURY USING ELEMENTAL REDUCING AGENTS | $4M | FY2017 | Sep 2017 – Aug 2021 |
| Department of Health and Human Services | CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER GENOMICS - CANCERGEN | $4M | FY2009 | Sep 2009 – Aug 2011 |
| Department of Health and Human Services | PHOSPHORYLATION OF GAP JUNCTION PROTEINS | $4M | FY1997 | May 1997 – Aug 2019 |
| Department of Health and Human Services | LINEAGE DETERMINATION IN MUSCLE | $3.9M | FY1998 | May 1998 – Apr 2019 |
| Department of Health and Human Services | CHLOROTOXIN AS A TARGETING AGENT FOR CANCER THERAPIES | $3.8M | FY2008 | Jul 2008 – Aug 2020 |
| Department of Health and Human Services | TAMOXIFEN & SECOND BREAST CANCER: EPIDEMIOLOGY/PATHOLOGY | $3.8M | FY2003 | Jun 2003 – Dec 2014 |
| Department of Health and Human Services | MECHANISM OF INCREASE GENOMIC INSTABILITY IN AGING YEAST | $3.8M | FY2004 | Jun 2004 – May 2021 |
| Department of Health and Human Services | ENGRAFTMENT AND IN VIVO SELECTION OF HIV-PROTECTED STEM CELLS | $3.8M | FY2012 | Aug 2012 – May 2019 |
| Department of Health and Human Services | IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTS (HCT) | $3.7M | FY2009 | Sep 2009 – Aug 2016 |
| Department of Health and Human Services | ROLE OF THE MICROBIOME IN HIV VACCINE INDUCED HETEROGENEITY | $3.6M | FY2016 | Sep 2016 – Aug 2021 |
| Department of Health and Human Services | TELEPHONE-DELIVERED ACCEPTANCE AND COMMITMENT THERAPY FOR SMOKING CESSATION | $3.5M | FY2015 | Feb 2015 – Nov 2020 |
| Department of Health and Human Services | CTRIP:NOTCH-MEDIATED EXPANSION OF CORD BLOOD PROGENITORS FOR CORD BLOOD TRANSPLAN | $3.5M | FY2009 | Sep 2009 – Aug 2011 |
| Department of Health and Human Services | PRECLINICAL GENE THERAPY STUDIES IN CANINE MUSCULAR DYSTROPHY | $3.5M | FY2009 | Dec 2008 – Jun 2016 |
| Department of Health and Human Services | INTERNET STUDIES TO ENHANCE LONG TERM SURVIVORSHIP AFTER HEMATOLOGIC MALIGNANCY | $3.4M | FY2011 | Sep 2011 – Jul 2017 |
| Department of Health and Human Services | RANDOMIZED TRIAL OF WEB-DELIVERED ACCEPTANCE THERAPY FOR SMOKING CESSATION | $3.4M | FY2013 | Jan 2013 – Dec 2019 |
| Department of Health and Human Services | EVALUATION OF PLURIPOTENT STEM CELL-DERIVED BLOOD CELLS IN NONHUMAN PRIMATE MODEL | $3.3M | FY2013 | Aug 2013 – Oct 2017 |
| Department of Health and Human Services | ESOPHAGEAL CANCER FROM CELLS TO POPULATION: A MULTISCALE APPROACH | $3.3M | FY2013 | Sep 2013 – Aug 2019 |
| Department of Health and Human Services | IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND GENITAL MUCOSAL IMMUNITY | $3.3M | FY2008 | Aug 2008 – May 2012 |
| Department of Health and Human Services | MOLECULAR MECHANISMS OF GENETIC RECOMBINATION | $3.3M | FY1983 | Mar 1983 – — |
| Department of Health and Human Services | GUT MICROBIOTA AND COLONIC GENE EXPRESSION: A LIGRAN TRIAL IN HUMANS | $3.2M | FY2011 | Sep 2011 – Aug 2017 |
| Department of Health and Human Services | EXONIC VARIANTS AND THEIR RELATION TO COMPLEX TRAITS IN MINORITIES OF THE WHI | $3.2M | FY2013 | Sep 2013 – May 2019 |
| Department of Health and Human Services | BIOLOGY AND PROGNOSTIC IMPLICATIONS OF FLT3 MUTATIONS IN AML | $3.2M | FY2005 | Aug 2005 – Jul 2019 |
| Department of Health and Human Services | DEEP SEQUENCING FOR MINIMAL RESIDUAL DISEASE DETECTION IN ACUTE LYMPHOBLASTIC LEU | $3.1M | FY2014 | May 2014 – Apr 2020 |
| Department of Health and Human Services | EMPLOYING THE MYC TRANSCRIPTIONAL NETWORK TO REVEAL ONCOGENIC PATHWAYS | $3.1M | FY1991 | Sep 1991 – Jun 2019 |
| Department of Health and Human Services | WHOLE GENOME SEQUENCE ANALYSIS OF ISCHEMIC STROKE IN THE WOMEN'S HEALTH INITIATIVE | $3.1M | FY2017 | Apr 2017 – Jan 2022 |
| Department of Health and Human Services | AFFINITY BASED STRATEGIES TO FAST TRACK DEVELOPMENT OF COLON CANCER BIOMARKERS | $3.1M | FY2010 | Aug 2010 – Jun 2016 |
| Department of Health and Human Services | LEUKOCYTE TELOMERE LENGTH AND CARDIOVASCULAR DISEASE IN JACKSON HEART STUDY | $3.1M | FY2013 | Aug 2013 – May 2019 |
| Department of Health and Human Services | RANDOMIZED TRIAL OF AN INNOVATIVE SMARTPHONE INTERVENTION FOR SMOKING CESSATION | $3.1M | FY2015 | Jun 2015 – May 2021 |
| Department of Health and Human Services | STIMULATION OF TUMORIGENESIS BY NKG2D | $3.1M | FY1991 | Jul 1991 – Jan 2018 |
| Department of Health and Human Services | ACCEPTANCE & COMMITMENT THERAPY FOR SMOKING CESSATION | $3M | FY2010 | Jul 2010 – Apr 2015 |
| Department of Health and Human Services | HUTCHINSON CENTER AS LEAD ACADEMIC PARTICIPATING SITE (U10) | $3M | FY2014 | May 2014 – Feb 2019 |
| Department of Health and Human Services | A PROSPECTIVE STUDY OF COLORECTAL CANCER: ONE-CARBON METABOLISM AND INFLAMMATION | $3M | FY2008 | Apr 2008 – Jan 2013 |
| Department of Health and Human Services | BIOCONDUCTOR: AN OPEN COMPUTING RESOURCE FOR GENOMICS | $3M | FY2006 | Sep 2006 – Sep 2011 |
| Department of Health and Human Services | THE STATISTICAL AND COMPUTATIONAL ANALYSIS OF FLOW CYTOMETRY DATA | $2.9M | FY2008 | May 2008 – Dec 2016 |
| Department of Health and Human Services | PAVING THE WAY FOR A NOVEL THERAPEUTIC APPROACH TO COMBAT HIV | $2.9M | FY2012 | Sep 2012 – Jun 2017 |
| Department of Health and Human Services | SINGLE-CELL METHODS FOR ANALYSIS OF CLONAL HETEROGENEITY AND EVOLUTION IN CANCER | $2.9M | FY2013 | May 2013 – Apr 2020 |
| Department of Health and Human Services | HUMAN AND BACTERIAL MOLECULAR PATHWAYS IN CANCER RISK: MODULATION BY DIET | $2.9M | FY2016 | Dec 2015 – Nov 2019 |
| Department of Health and Human Services | CD8+T CELL IMMUNITY TO CYTOMEGALOVIRUS | $2.9M | FY2003 | Jan 2003 – Jan 2014 |
| Department of Health and Human Services | PROMISS - PROSTATE MODELING TO IDENTIFY SURVEILLANCE STRATEGIES | $2.9M | FY2013 | Sep 2013 – Aug 2019 |
| Department of Health and Human Services | ORAL CANCER: MOLECULAR PROFILES & CLINICAL OUTCOMES | $2.8M | FY2003 | Jun 2003 – Aug 2011 |
| Department of Health and Human Services | CROSS-SPECIES NETWORK APPROACH TO PREDICT EPISTATIC CANCER SUSCEPTIBILITY GENES | $2.8M | FY2008 | Sep 2008 – Aug 2013 |
| Department of Health and Human Services | DEVELOPMENT OF SAFE AND EFFICIENT GENE THERAPY STRATEGIES FOR HEMOGLOBINOPATHIES | $2.8M | FY2010 | Jan 2010 – Dec 2014 |
| VA/DoDDepartment of Defense | BIOMARKERS FOR EARLY DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER: A MULTI-INSTITUTIONAL VALIDATION TRIAL | $2.8M | FY2014 | Sep 2014 – Sep 2017 |
| Department of Health and Human Services | CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN | $2.8M | FY2012 | Aug 2012 – Mar 2017 |
| Department of Health and Human Services | REGULATION OF CENTROMERIC CHROMATIN | $2.7M | FY2007 | Sep 2007 – Jan 2017 |
| Department of Health and Human Services | NAIVE T CELL DEPLETION TO PREVENT GRAFT-VERSUS-HOST DISEASE | $2.7M | FY2014 | Sep 2014 – May 2019 |
| Department of Health and Human Services | INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY | $2.7M | FY2013 | Apr 2013 – Mar 2018 |
| Department of Health and Human Services | NOVEL BIOMARKERS TO RISK-STRATIFY AML PATIENTS WITH NPM1^POS/FLT3-IT^NEG GENOTYPE | $2.7M | FY2016 | Apr 2016 – Mar 2022 |
| Department of Health and Human Services | PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM | $2.7M | FY2005 | Sep 2005 – Feb 2013 |
| Department of Health and Human Services | CELLULAR COOPERATION AND CHEATING: AN EXPERIMENTAL AND MATHEMATICAL ANALYSIS | $2.6M | FY2009 | Sep 2009 – Aug 2014 |
| Department of Health and Human Services | INTEGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF FOOD INTAKE | $2.6M | FY2010 | Jan 2010 – Dec 2014 |
| Department of Health and Human Services | NOVEL PATHOGEN ASSOCIATED CANCERS (PQ12) | $2.6M | FY2012 | Sep 2012 – Jan 2017 |
| Department of Health and Human Services | STATISTICAL METHODS FOR MEDICAL TESTS AND BIOMARKERS | $2.6M | FY1996 | May 1996 – — |
| Department of Health and Human Services | THE COLONIC MICROBIOTA AND IMMUNITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION | $2.6M | FY2016 | Apr 2016 – Mar 2021 |
| Department of Health and Human Services | STATISTICAL METHODS FOR PROSPECTIVE EVALUATION OF BIOMARKERS | $2.6M | FY2009 | Sep 2009 – Jun 2019 |
| Department of Health and Human Services | EPIDEMIOLOGIC FACTORS AND SURVIVAL BY MOLECULAR SUBTYPES OF OVARIAN CANCER | $2.6M | FY2013 | Apr 2013 – Mar 2019 |
| Department of Health and Human Services | A COHORT STUDY OF SESSILE SERRATED POLYPS AND SUBSEQUENT COLORECTAL NEOPLASIA | $2.6M | FY2013 | Apr 2013 – Mar 2019 |
| Department of Health and Human Services | GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES IN THE WHI | $2.6M | FY2009 | Sep 2009 – Jul 2014 |
| Department of Health and Human Services | TOGETHER WE STRIDE (STRATEGIZING TOGETHER RELEVANT INTERVENTIONS FOR DIET AND EXERCISE) | $2.5M | FY2016 | Apr 2016 – Dec 2021 |
| Department of Health and Human Services | MECHANISMS OF CELL CYCLE ASSOCIATED NEOPLASIA | $2.5M | FY2000 | Feb 2000 – Apr 2016 |
| Department of Health and Human Services | IMPROVING ENGRAFTMENT OF HEMATOPOIETIC STEM CELL GENE THERAPY | $2.5M | FY2015 | Sep 2015 – Aug 2021 |
| Department of Health and Human Services | MOLECULAR CORRELATES OF OUTCOMES IN CLINICAL TRIALS OF COLON CANCER | $2.5M | FY2013 | Apr 2013 – Mar 2020 |
| Department of Health and Human Services | NIGHT SHIFT WORK AND HORMONE LEVELS IN MEN | $2.5M | FY2007 | Jul 2007 – May 2012 |
| Department of Health and Human Services | LAGLIDADG DELIVERY AND GENE REPAIR IN CANINE HEMATOPOIETIC STEM CELLS (7 OF 11) | $2.5M | FY2007 | Sep 2007 – Jun 2012 |
| Department of Health and Human Services | STATISTICAL METHODS FOR ADHERENCE ISSUES IN HIV PREVENTION RESEARCH | $2.5M | FY2015 | Jul 2015 – Jun 2020 |
| Department of Health and Human Services | IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTS (HCT) | $2.5M | FY2009 | Sep 2009 – Aug 2014 |
| Department of Health and Human Services | MECHANISMS OF ENVIRONMENTAL AND NUCLEAR AND MITOCHONDRIAL MUTAGENESIS | $2.5M | FY2010 | Sep 2010 – Apr 2015 |
| Department of Health and Human Services | DISCOVERY AND OPTIMIZATION OF AML PROGNOSTIC BIOMARKERS | $2.5M | FY2012 | May 2012 – Mar 2018 |
| Department of Health and Human Services | HYBRID PLASMA MARKERS THAT COMPLEMENT CT IMAGING FOR EARLY LUNG CANCER DETECTION | $2.5M | FY2015 | Apr 2015 – Mar 2021 |
| Department of Health and Human Services | MICROCHIMERISM AS ALLOIMMUNITY | $2.4M | FY2014 | Mar 2014 – Feb 2020 |
| Department of Health and Human Services | SEATTLE VACCINE TRIALS UNIT | $2.4M | FY2007 | Feb 2007 – Dec 2013 |
| Department of Health and Human Services | THE IMPACT OF PRENATAL EXPOSURE TO PERSISTENT ORGANIC POLLUTANTS ON KINETICS OF IMMUNE RESPONSE TO VACCINES AND SERO-PROTECTION IN INFANTS | $2.4M | FY2016 | Aug 2016 – Apr 2021 |
| Department of Health and Human Services | TELOMERES AND LUNG CANCER INCIDENCE AND SURVIVAL | $2.4M | FY2011 | Aug 2011 – Aug 2017 |
| Department of Health and Human Services | SHWACHMAN-DIAMOND SYNDROME: MOLECULAR PATHOGENESIS | $2.4M | FY2004 | Sep 2004 – May 2013 |
| Department of Health and Human Services | EPIGENOMIC PROFILING OF HISTONE TURNOVER KINETICS IN MAMMALIAN CELLS | $2.4M | FY2010 | Sep 2010 – Dec 2015 |
| Department of Health and Human Services | STATISTICAL METHODS FOR COMBINATION HIV PREVENTION APPROACHES | $2.4M | FY2014 | Jul 2014 – Feb 2019 |
| VA/DoDDepartment of Defense | USE OF SELENIDE TO IMPROVE OUTCOME IN REPERFUSION INJURY | $2.3M | FY2014 | Jun 2014 – Dec 2017 |
| Department of Health and Human Services | IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD | $2.3M | FY2007 | Jul 2007 – May 2012 |
| Department of Health and Human Services | DISCOVERING TISSUE-SPECIFIC BIOMARKERS OF RADIATION INJURY IN SILAC-LABELED MICE | $2.3M | FY2012 | Jun 2012 – May 2018 |
| Department of Health and Human Services | ESTIMATING OVERDIAGNOSIS IN CANCER SCREENING STUDIES | $2.3M | FY2015 | May 2015 – Oct 2020 |
| Department of Health and Human Services | NORMAL AND NEOPLASTIC REGULATION OF CYCLIN E | $2.2M | FY2003 | Jul 2003 – Dec 2013 |
| Department of Health and Human Services | SRC FAMILY KINASES AND CELL GROWTH REGULATION | $2.2M | FY1986 | Jan 1986 – Dec 2011 |
| Department of Health and Human Services | DEVELOPMENT OF NOVEL AIDS GENE THERAPY STRATEGIES IN THE MACAQUE SHIV MODEL | $2.2M | FY2010 | May 2010 – Aug 2013 |
| Department of Health and Human Services | INVESTIGATING CREBBP AS A TUMOR SUPPRESSOR IN SMALL CELL LUNG CANCER | $2.2M | FY2017 | Dec 2016 – Nov 2021 |
| Department of Health and Human Services | MYC-DEPENDENT LOSS OF SPLICING FIDELITY IN GLIOBLASTOMA MULTIFORME | $2.2M | FY2015 | Aug 2015 – Jul 2021 |
| Department of Health and Human Services | MINIMIZING MASS PANIC WITH SALIVA TESTS FOR RADIATION EXPOSURE | $2.2M | FY2008 | Jun 2008 – May 2013 |
| Department of Health and Human Services | GENETIC ANALYSIS OF AIRFLOW OBSTRUCTION AFTER STEM CELL TRANSPLANTATION | $2.2M | FY2008 | Jun 2008 – May 2014 |
| Department of Health and Human Services | MECHANISMS OF ORGANELLE DETERIORATION | $2.2M | FY2011 | Apr 2011 – Mar 2017 |
| Department of Health and Human Services | STATINS FOR PREVENTION OF GVHD | $2.2M | FY2011 | Apr 2011 – Jun 2017 |
| Department of Health and Human Services | ALPHA-CATENIN IN REGULATION OF TISSUE HOMEOSTASIS AND CANCER | $2.2M | FY2014 | Jun 2014 – May 2019 |
| Department of Health and Human Services | REGULATORY T CELL MODULATION OF IMMUNITY TO MUCOSAL VIRAL INFECTIONS | $2.2M | FY2010 | Jun 2010 – May 2015 |
| Department of Health and Human Services | CYTOTOXIC T-CELL RESPONSES TO HSV IN HIV-INFECTED PERSONS | $2.1M | FY1998 | Dec 1997 – Mar 2018 |
| Department of Health and Human Services | T CELL MODULATION BY NKG2D | $2.1M | FY2002 | Sep 2002 – Aug 2014 |
| Department of Health and Human Services | ELUCIDATION OF A BACTERIAL CELL SHAPE GENERATING PROGRAM AND PATHOGENIC FUNCTIONS | $2.1M | FY2012 | Dec 2011 – Dec 2016 |
| Department of Health and Human Services | TILLING THE ZEBRAFISH GENOME: A REVERSE GENETIC APPROACH | $2.1M | FY2008 | Sep 2008 – Aug 2011 |
| Department of Health and Human Services | ADOPTIVE T CELL THERAPY OF MELANOMA TARGETING NY-ESO-1 | $2.1M | FY2004 | Apr 2004 – Jan 2015 |
| Department of Health and Human Services | MECHANISMS OF TANGENTIAL NEURON MIGRATION | $2.1M | FY2013 | Sep 2013 – May 2018 |
| Department of Health and Human Services | DYNAMICS OF GRADIENT SENSING IN SINGLE CELLS | $2.1M | FY2011 | Apr 2011 – Mar 2018 |
| Department of Health and Human Services | "NEUTROPHIL ELASTASE LINKS IDIOPATHIC PULMONARY FIBROSIS AND LUNG CANCER" | $2.1M | FY2011 | Jul 2011 – Jun 2016 |
| Department of Health and Human Services | DISSECTING THE MECHANISM OF INCREASED GENOMIC INSTABILITY IN AGING YEAST | $2M | FY2004 | Jun 2004 – May 2020 |
| Department of Health and Human Services | POPULATION PHARMACOKINETICS/PHARMACODYNAMICS IN NONABLATIVE STEM CELL RECIPIENTS | $2M | FY2008 | Mar 2008 – Dec 2011 |
| Department of Health and Human Services | NOVEL CULTIVATION METHODS FOR THE DOMESTICATION OF VAGINAL BACTERIA | $2M | FY2010 | Aug 2010 – Jun 2013 |
| Department of Health and Human Services | FFPE VALIDATION OF A SURVIVAL GENE SIGNATURE IN HPV-NEGATIVE ORAL CAVITY CANCER | $2M | FY2015 | Jan 2015 – Dec 2020 |
| Department of Health and Human Services | NORMAL AND CANCER STEM CELLS OF THE MAMMARY GLAND | $2M | FY2009 | Jul 2009 – Jul 2013 |
| Department of Health and Human Services | INTERROGATION OF MLL2 AS A TUMOR SUPPRESSOR GENE IN LUNG CANCER | $2M | FY2015 | Mar 2015 – Feb 2020 |
| Department of Health and Human Services | HIGH-PERFORMANCE COMPUTE CLUSTER FOR COMPREHENSIVE CANCER AND INFECTIOUS DISEASES RESEARCH | $2M | FY2020 | Apr 2020 – Mar 2022 |
| Department of Health and Human Services | IRS-1 REGULATES INFLAMMATORY CELL RECRUITMENT IN LUNG CANCER | $2M | FY2015 | Mar 2015 – Feb 2020 |
| Department of Health and Human Services | CHEMOPROTECTION AGAINST AMINOGLYCOSIDE-INDUCED OTOTOXICITY | $2M | FY2009 | Aug 2009 – Jul 2014 |
| Department of Health and Human Services | PREVENTING TUMOR RELAPSE WITH BIOMATERIAL-SUPPORTED LYMPHOCYTE IMPLANTS | $2M | FY2014 | Jan 2014 – Dec 2018 |
| Department of Health and Human Services | CELL-STRESS INDUCED IMMUNE RESPONSES | $1.9M | FY1991 | Jul 1991 – Apr 2011 |
| Department of Health and Human Services | USING GENETICALLY ENGINEERED MOUSE MODELS OF BRAIN TUMORS TO DEVELOP THERAPEUTIC NANOPARTICLES & BIOMATERIALS | $1.9M | FY2016 | Dec 2015 – Nov 2019 |
Department of Health and Human Services
$102.1M
LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIALS NETWORK
Department of Health and Human Services
$65.8M
LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; MICROBICIDE TRIALS NETWORK
Department of Health and Human Services
$49.6M
HVTN LABORATORY PROGRAM
Department of Health and Human Services
$29.8M
LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HIV VACCINE TRIALS NETWORK
Department of Health and Human Services
$28.8M
SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
Department of Health and Human Services
$25.1M
ELICITING VRC01-LIKE BNABS BY SPECIFICALLY DESIGNED ENV IMMUNOGENS
Department of Health and Human Services
$23M
PERSONAL PROTECTIVE EQUIPMENT FOR RESOURCES FOR COVID-19 RELATED VACCINE AND TREATMENT CLINICAL TRIALS AND CLINICAL STUDIES
Department of Health and Human Services
$22M
BARRETT'S ESOPHAGUS: PREDICTORS OF PROGRESSION
Department of Health and Human Services
$20.8M
TARGETED MODIFICATION OF HOST AND PROVIRAL DNA TO TREAT LATENT HIV INFECTION
Department of Health and Human Services
$17.3M
LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HIV PREVENTION TRIALS NETWORK
Department of Health and Human Services
$16.7M
CANCER IMMUNOTHERAPY TRIALS NETWORK CENTRAL OPERATIONS AND STATISTICAL CENTER
Department of Health and Human Services
$15M
THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES
Department of Health and Human Services
$14.9M
PERSONAL PROTECTIVE EQUIPMENT FOR RESOURCES FOR COVID-19 RELATED VACCINE AND TREATMENT CLINICAL TRIALS AND CLINICAL STUDIES - PROJECT SUMMARY/ABSTRACT PLANNED COVID-19 VACCINE TRIALS REQUIRE SCREENING, ENROLLING, AND FOLLOWING OVER 150,000 VOLUNTEER STUDY PARTICIPANTS OVER 24 MONTHS. THE TRIAL PARTICIPANTS WILL BE SELECTED BASED ON THEIR RISK OF COVID-19 INFECTION, WITH TRIAL PARTICIPANTS COMING FROM SETTINGS WITH HIGH RATES OF COMMUNITY TRANSMISSION, GROUPS WITH HIGHER RISK OF PROGRESSION TO SYMPTOMATIC DISEASE, OR BOTH. STUDY STAFF WORKING ON COVID-19 VACCINE TRIALS WILL NEED TO INTERACT WITH TRIAL PARTICIPANTS DURING REGULAR VISITS AS WELL AS CONDUCTING IN-PERSON ASSESSMENTS OF ALL VACCINE TRIAL PARTICIPANTS WITH SYMPTOMS THAT COULD BE DUE TO COVID-19 DISEASE. THIS WILL RESULT IN CLOSE CONTACT BETWEEN STUDY STAFF AND HIGH-RISK PARTICIPANTS OR INFECTED PARTICIPANTS. AS A RESULT, STUDY STAFF NEED TO ACCESS A REGULAR SUPPLY OF PERSONAL PROTECTIVE EQUIPMENT (PPE), INCLUDING SURGICAL MASKS, FACE SHIELDS OR GOGGLES, GOWNS, AND DISPOSABLE GLOVES, AS WELL AS THE ABILITY TO SANITIZE HANDS FREQUENTLY. THIS COMBINATION OF PPE WILL BE USED DURING ALL RISKY INTERACTIONS WITH STUDY PARTICIPANTS, SUCH AS DURING NASAL SWAB COLLECTION AND DURING EVALUATION OF PARTICIPANTS FOR POSSIBLE STUDY ENDPOINTS, INCLUDING SYMPTOMATIC COVID-19 DISEASE. IN ADDITION, ALL STAFF WILL NEED TO WEAR SURGICAL FACE MASKS DURING AND THROUGHOUT THEIR NORMAL WORKDAY IN THE HEALTH CARE SETTING OR ON SITE FOR MOBILE STUDY SATELLITE SITES. WITHOUT APPROPRIATE PPE, HEALTH CARE WORKERS ARE VULNERABLE TO INFECTION WITH COVID-19, AS WELL AS PASSIVELY TRANSMITTING TO PERSONS WITH WHOM THEY ARE IN CLOSE PHYSICAL CONTACT. ACCESS TO ADEQUATE PPE IS A CRITICAL COMPONENT OF THE SAFE AND EFFECTIVE CONDUCT OF COVID-19 VACCINE TRIALS, AND WILL ENABLE ACCURATE DETERMINATION OF THE STUDY ENDPOINTS, ESPECIALLY SYMPTOMATIC COVID- 19 DISEASE.
Department of Health and Human Services
$14.6M
PACIFIC OVARIAN CANCER RESEARCH CONSORITUM
Department of Health and Human Services
$13.5M
MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS FOR SWEATS AND HOT FLASHES
Department of Health and Human Services
$12.5M
CENTER FOR STATISTICS AND QUANTITATIVE INFECTIOUS DISEASES
Department of Health and Human Services
$12.4M
DETECTION OF COLORECTAL CANCER SUSCEPTIBILITY LOCI USING GENOME-WIDE SEQUENCING
Department of Health and Human Services
$12.4M
NOTCH-MEDIATED EXPANSION OF CORD BLOOD PROGENITORS FOR STEM CELL TRANSPLANT
Department of Health and Human Services
$12.3M
THE PATHOGENESIS OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Department of Health and Human Services
$12.1M
WOMEN'S HEALTH INITIATIVE CANCER SURVIVOR COHORT
Department of Health and Human Services
$11M
SEATTLE CANCER CONSORTIUM BREAST SPORE
Department of Health and Human Services
$10.1M
LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; MICROBICIDE TRIALS NETWORK
Department of Health and Human Services
$10M
TREC COORDINATION CENTER
Department of Health and Human Services
$9.9M
EPIDEMIOLOGY OF PUTATIVE GENUINE GENETIC VARIANT: THE WOMEN'S HEALTH INTIATIVE
Department of Health and Human Services
$9.8M
WHOLE GENOME ASSOCIATION ANALYSIS OF HEMATOPOIETIC CELL TRANSPLANT (HCT) OUTCOME
Department of Health and Human Services
$9.7M
RADIATION DOSE-DEPENDENT INTERVENTIONS
Department of Health and Human Services
$9.7M
UNDERSTANDING AND PREVENTING BREAST CANCER DISPARTIES IN LATINAS
Department of Health and Human Services
$9.6M
DATA CENTER CORE CONSOLIDATION
Department of Health and Human Services
$9.1M
HPV: BIOLOGY, CLINICAL SIGNIFICANCE AND EPIDEMIOLOGY
Department of Health and Human Services
$8.9M
MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN
Department of Health and Human Services
$8.4M
STEM CELL TRANSPLANTATION: BASIC/CLINICAL RESEARCH
Department of Health and Human Services
$8.4M
MOLECULAR ANALYSIS OF EUKARYOTIC TRANSCRIPTION
Department of Health and Human Services
$8.4M
EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WNT AND NOTCH
Department of Health and Human Services
$8.3M
CONTROLLING HEMATOPOIETIC LINEAGE COMMITMENT FROM ESC TO PLATELETS
Department of Health and Human Services
$7.8M
BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTIBILITY STUDY (BEAGESS)
Department of Health and Human Services
$7.7M
LATE EFFECTS OF TREATMENT IN WILMS TUMOR SURVIVORS AND OFFSPRING
Department of Health and Human Services
$7.7M
MOLECULAR CONTROL OF HEMATOPOIETIC STEM CELL FATE
Department of Health and Human Services
$7.5M
GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN COLON CANCER
Department of Health and Human Services
$7.5M
PROSPR STATISTICAL COORDINATING CENTER (PSCC)
Department of Health and Human Services
$7.4M
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1
Department of Health and Human Services
$7.3M
CORE CENTER OF EXCELLENCE IN HEMATOLOGY
Department of Health and Human Services
$7.2M
MSFLASH: LIVING A HEALTHY MENOPAUSE
Department of Health and Human Services
$7.1M
FUNCTION OF HUMAN & MOUSE BETA-GLOBIN LOCUS CONTROL REGIONS
Department of Health and Human Services
$7.1M
MAINTENANCE OF GENE EXPRESSION IN THE RED CELL LINEAGE
Department of Health and Human Services
$7M
THE COLON CANCER FAMILY REGISTRY: SEATTLE
Department of Health and Human Services
$6.6M
HIV TESTING AND TREATMENT TO PREVENT ONWARD HIV TRANSMISSION AMONG HIGH-RISK MSM
Department of Defense
$6.6M
IMPROVING OUTCOME FOR HEMORRHAGIC SHOCK USING INHIBITORS OF OXIDATIVE PHOSPHORYLATION
Department of Health and Human Services
$6.5M
MECHANISMS OF EUKARYOTIC TRANSCRIPTION ACTIVATION
Department of Health and Human Services
$6.2M
REGULATION OF CELL GROWTH AND PROLIFERATION BY MYC
Department of Health and Human Services
$6.1M
IMMUNOBIOLOGY OF TOLERANCE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATIO
Department of Health and Human Services
$6M
MECHANISMS AND FUNCTIONS OF ATP-DEPENDENT CHROMATIN REMODELING
Department of Health and Human Services
$5.9M
MOLECULAR ANALYSIS OF HOTSPOTS OF GENETIC RECOMBINATION
Department of Health and Human Services
$5.9M
CONTAINING BIOTERROIST AND EMERGING INFECTIOUS DISEASES
Department of Health and Human Services
$5.9M
A RANDOMZIED PHASE II TRIAL OF CMV PREVENTION IN ACUTE LUNG INJURY
Department of Health and Human Services
$5.8M
MONITORING THE DEVELOPMENT OF ANTI-ENV ABS DURING HIV INFECTION
Department of Health and Human Services
$5.5M
DISCOVERY AND VERIFICATION OF NOVEL BIOMARKERS OF COLORECTAL CANCER RECURRENCE
Department of Health and Human Services
$5.5M
TARGETED THERAPY OF ALL WITH GENE-MODIFIED CENTRAL MEMORY T CELLS
Department of Health and Human Services
$5.5M
THE ROLE OF UNCULTIVATED BACTERIA IN BACTERIAL VAGINOSIS
Department of Health and Human Services
$5.4M
PROACTIVE SMOKING CESSATION FOR ADOLESCENTS
Department of Health and Human Services
$5.3M
MODELING PROSTATE CANCER CONTROL: PREVENTION SCREENING TREATMENT FOLLOWUP CARE
Department of Health and Human Services
$5.2M
MODELING TO IMPROVE PROSTATE CANCER OUTCOMES ACROSS DIVERSE POPULATIONS
Department of Health and Human Services
$5.2M
MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION
Department of Health and Human Services
$5.1M
PCPT AND SELECT COHORTS: CORE INFRASTRUCTURE SUPPORT FOR CANCER RESEARCH
Department of Health and Human Services
$5.1M
HIV HOST-CELL INTERACTIONS
Department of Health and Human Services
$5M
STATISTICAL METHODS FOR MEDICAL STUDIES
Department of Health and Human Services
$4.9M
OBJECTIVE PHYSICAL ACTIVITY AND CARDIOVASCULAR HEALTH IN WOMEN AGED 80 AND OLDER
Department of Health and Human Services
$4.8M
MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN COMPLEX BIOLOGICAL SAMPLES
Department of Health and Human Services
$4.8M
INTERACTIONS OF HPV ONCOGENES WITH THE P53 PATHWAY
Department of Health and Human Services
$4.7M
EPIDEMIOLOGY OF THE FOUR MOST FREQUENT CANCERS FOLLOWING BREAST CANCER
Department of Defense
$4.7M
USE OF DEPO-MEDROXYPROGESTERONE ACETATE AND RISK OF PREMENOPAUSAL BREAST CANCER
Department of Health and Human Services
$4.7M
CENTER FOR HISPANIC HEALTH PROMOTION: REDUCING CANCER DISPARITIES
Department of Health and Human Services
$4.6M
ROLE OF THE PERIVASCULAR MICROENVIRONMENT IN PRIMARY AND METASTATIC BRAIN TUMORS
Department of Defense
$4.6M
ADVANCING OUR UNDERSTANDING OF THE ETIOLOGIES AND MUTATIONAL LANDSCAPES OF BASAL-LIKE, LUMINAL A, AND LUMINAL B BREAST CANCERS
Department of Health and Human Services
$4.6M
METHODS FOR EVALUATING VACCINE EFFICACY
Department of Health and Human Services
$4.6M
BREAST CANCER RISK AND MOLECULAR CHANGE AFTER CHERNOBYL
Department of Health and Human Services
$4.5M
EDRN:DATA MANAGEMENT AND COORDINATING CENTER
Department of Health and Human Services
$4.4M
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
Department of Health and Human Services
$4.4M
HPV CAPSID ANTIBODIES
Department of Health and Human Services
$4.3M
TRANSLATIONAL CONTROL OF CYTOMEGALOVIRUS GENE EXPRESSION
Department of Health and Human Services
$4.3M
PROFILING CANCER NEOANTIGEN REPERTOIRES AND VALIDATING IMMUNOTHERAPY TARGETS
Department of Health and Human Services
$4.2M
MYC ONCOPROTEIN FUNCTION
Department of Health and Human Services
$4.2M
PHYSICAL ACTIVITY TO IMPROVE CV HEALTH IN OLDER WOMEN: A PRAGMATIC TRIAL -- DCC
Department of Defense
$4.2M
TARGETING TUMOR DORMANCY TO PREVENT METASTATIC RELAPSE
Department of Health and Human Services
$4.2M
P3IK SIGNALING AND BIOLOGY OF THERAPEUTIC RESPONSE IN BRAIN AND PROSTATE TUMORS
Department of Health and Human Services
$4.1M
AN INTEGRATED COMPUTATIONAL AND FUNCTIONAL GENOMICS DISCOVERY ENGINE FOR PRECLINI
Department of Health and Human Services
$4.1M
DEFINING THE INFANT IMMUNE RESPONSE TO HIV
Department of Health and Human Services
$4.1M
BIOLOGIC DETERMINANTS OF THE NATURAL HISTORY OF AIDS-DEFINING CANCERS IN UGANDA
Department of Health and Human Services
$4M
TUMOR MAINTENANCE AND DEVELOPMENT IN MOUSE MODELS
Department of Health and Human Services
$4M
RNA AS A HORMONE: SYSTEMIC SIGNALING IN MAMMALS VIA CIRCULATING, CELL-FREE SMALL
Department of Defense
$4M
IMPROVING OUTCOME IN ISCHEMIA AND ISCHEMIA REPERFUSION INJURY USING ELEMENTAL REDUCING AGENTS
Department of Health and Human Services
$4M
CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER GENOMICS - CANCERGEN
Department of Health and Human Services
$4M
PHOSPHORYLATION OF GAP JUNCTION PROTEINS
Department of Health and Human Services
$3.9M
LINEAGE DETERMINATION IN MUSCLE
Department of Health and Human Services
$3.8M
CHLOROTOXIN AS A TARGETING AGENT FOR CANCER THERAPIES
Department of Health and Human Services
$3.8M
TAMOXIFEN & SECOND BREAST CANCER: EPIDEMIOLOGY/PATHOLOGY
Department of Health and Human Services
$3.8M
MECHANISM OF INCREASE GENOMIC INSTABILITY IN AGING YEAST
Department of Health and Human Services
$3.8M
ENGRAFTMENT AND IN VIVO SELECTION OF HIV-PROTECTED STEM CELLS
Department of Health and Human Services
$3.7M
IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTS (HCT)
Department of Health and Human Services
$3.6M
ROLE OF THE MICROBIOME IN HIV VACCINE INDUCED HETEROGENEITY
Department of Health and Human Services
$3.5M
TELEPHONE-DELIVERED ACCEPTANCE AND COMMITMENT THERAPY FOR SMOKING CESSATION
Department of Health and Human Services
$3.5M
CTRIP:NOTCH-MEDIATED EXPANSION OF CORD BLOOD PROGENITORS FOR CORD BLOOD TRANSPLAN
Department of Health and Human Services
$3.5M
PRECLINICAL GENE THERAPY STUDIES IN CANINE MUSCULAR DYSTROPHY
Department of Health and Human Services
$3.4M
INTERNET STUDIES TO ENHANCE LONG TERM SURVIVORSHIP AFTER HEMATOLOGIC MALIGNANCY
Department of Health and Human Services
$3.4M
RANDOMIZED TRIAL OF WEB-DELIVERED ACCEPTANCE THERAPY FOR SMOKING CESSATION
Department of Health and Human Services
$3.3M
EVALUATION OF PLURIPOTENT STEM CELL-DERIVED BLOOD CELLS IN NONHUMAN PRIMATE MODEL
Department of Health and Human Services
$3.3M
ESOPHAGEAL CANCER FROM CELLS TO POPULATION: A MULTISCALE APPROACH
Department of Health and Human Services
$3.3M
IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND GENITAL MUCOSAL IMMUNITY
Department of Health and Human Services
$3.3M
MOLECULAR MECHANISMS OF GENETIC RECOMBINATION
Department of Health and Human Services
$3.2M
GUT MICROBIOTA AND COLONIC GENE EXPRESSION: A LIGRAN TRIAL IN HUMANS
Department of Health and Human Services
$3.2M
EXONIC VARIANTS AND THEIR RELATION TO COMPLEX TRAITS IN MINORITIES OF THE WHI
Department of Health and Human Services
$3.2M
BIOLOGY AND PROGNOSTIC IMPLICATIONS OF FLT3 MUTATIONS IN AML
Department of Health and Human Services
$3.1M
DEEP SEQUENCING FOR MINIMAL RESIDUAL DISEASE DETECTION IN ACUTE LYMPHOBLASTIC LEU
Department of Health and Human Services
$3.1M
EMPLOYING THE MYC TRANSCRIPTIONAL NETWORK TO REVEAL ONCOGENIC PATHWAYS
Department of Health and Human Services
$3.1M
WHOLE GENOME SEQUENCE ANALYSIS OF ISCHEMIC STROKE IN THE WOMEN'S HEALTH INITIATIVE
Department of Health and Human Services
$3.1M
AFFINITY BASED STRATEGIES TO FAST TRACK DEVELOPMENT OF COLON CANCER BIOMARKERS
Department of Health and Human Services
$3.1M
LEUKOCYTE TELOMERE LENGTH AND CARDIOVASCULAR DISEASE IN JACKSON HEART STUDY
Department of Health and Human Services
$3.1M
RANDOMIZED TRIAL OF AN INNOVATIVE SMARTPHONE INTERVENTION FOR SMOKING CESSATION
Department of Health and Human Services
$3.1M
STIMULATION OF TUMORIGENESIS BY NKG2D
Department of Health and Human Services
$3M
ACCEPTANCE & COMMITMENT THERAPY FOR SMOKING CESSATION
Department of Health and Human Services
$3M
HUTCHINSON CENTER AS LEAD ACADEMIC PARTICIPATING SITE (U10)
Department of Health and Human Services
$3M
A PROSPECTIVE STUDY OF COLORECTAL CANCER: ONE-CARBON METABOLISM AND INFLAMMATION
Department of Health and Human Services
$3M
BIOCONDUCTOR: AN OPEN COMPUTING RESOURCE FOR GENOMICS
Department of Health and Human Services
$2.9M
THE STATISTICAL AND COMPUTATIONAL ANALYSIS OF FLOW CYTOMETRY DATA
Department of Health and Human Services
$2.9M
PAVING THE WAY FOR A NOVEL THERAPEUTIC APPROACH TO COMBAT HIV
Department of Health and Human Services
$2.9M
SINGLE-CELL METHODS FOR ANALYSIS OF CLONAL HETEROGENEITY AND EVOLUTION IN CANCER
Department of Health and Human Services
$2.9M
HUMAN AND BACTERIAL MOLECULAR PATHWAYS IN CANCER RISK: MODULATION BY DIET
Department of Health and Human Services
$2.9M
CD8+T CELL IMMUNITY TO CYTOMEGALOVIRUS
Department of Health and Human Services
$2.9M
PROMISS - PROSTATE MODELING TO IDENTIFY SURVEILLANCE STRATEGIES
Department of Health and Human Services
$2.8M
ORAL CANCER: MOLECULAR PROFILES & CLINICAL OUTCOMES
Department of Health and Human Services
$2.8M
CROSS-SPECIES NETWORK APPROACH TO PREDICT EPISTATIC CANCER SUSCEPTIBILITY GENES
Department of Health and Human Services
$2.8M
DEVELOPMENT OF SAFE AND EFFICIENT GENE THERAPY STRATEGIES FOR HEMOGLOBINOPATHIES
Department of Defense
$2.8M
BIOMARKERS FOR EARLY DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER: A MULTI-INSTITUTIONAL VALIDATION TRIAL
Department of Health and Human Services
$2.8M
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN
Department of Health and Human Services
$2.7M
REGULATION OF CENTROMERIC CHROMATIN
Department of Health and Human Services
$2.7M
NAIVE T CELL DEPLETION TO PREVENT GRAFT-VERSUS-HOST DISEASE
Department of Health and Human Services
$2.7M
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
Department of Health and Human Services
$2.7M
NOVEL BIOMARKERS TO RISK-STRATIFY AML PATIENTS WITH NPM1^POS/FLT3-IT^NEG GENOTYPE
Department of Health and Human Services
$2.7M
PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM
Department of Health and Human Services
$2.6M
CELLULAR COOPERATION AND CHEATING: AN EXPERIMENTAL AND MATHEMATICAL ANALYSIS
Department of Health and Human Services
$2.6M
INTEGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF FOOD INTAKE
Department of Health and Human Services
$2.6M
NOVEL PATHOGEN ASSOCIATED CANCERS (PQ12)
Department of Health and Human Services
$2.6M
STATISTICAL METHODS FOR MEDICAL TESTS AND BIOMARKERS
Department of Health and Human Services
$2.6M
THE COLONIC MICROBIOTA AND IMMUNITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
Department of Health and Human Services
$2.6M
STATISTICAL METHODS FOR PROSPECTIVE EVALUATION OF BIOMARKERS
Department of Health and Human Services
$2.6M
EPIDEMIOLOGIC FACTORS AND SURVIVAL BY MOLECULAR SUBTYPES OF OVARIAN CANCER
Department of Health and Human Services
$2.6M
A COHORT STUDY OF SESSILE SERRATED POLYPS AND SUBSEQUENT COLORECTAL NEOPLASIA
Department of Health and Human Services
$2.6M
GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES IN THE WHI
Department of Health and Human Services
$2.5M
TOGETHER WE STRIDE (STRATEGIZING TOGETHER RELEVANT INTERVENTIONS FOR DIET AND EXERCISE)
Department of Health and Human Services
$2.5M
MECHANISMS OF CELL CYCLE ASSOCIATED NEOPLASIA
Department of Health and Human Services
$2.5M
IMPROVING ENGRAFTMENT OF HEMATOPOIETIC STEM CELL GENE THERAPY
Department of Health and Human Services
$2.5M
MOLECULAR CORRELATES OF OUTCOMES IN CLINICAL TRIALS OF COLON CANCER
Department of Health and Human Services
$2.5M
NIGHT SHIFT WORK AND HORMONE LEVELS IN MEN
Department of Health and Human Services
$2.5M
LAGLIDADG DELIVERY AND GENE REPAIR IN CANINE HEMATOPOIETIC STEM CELLS (7 OF 11)
Department of Health and Human Services
$2.5M
STATISTICAL METHODS FOR ADHERENCE ISSUES IN HIV PREVENTION RESEARCH
Department of Health and Human Services
$2.5M
IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTS (HCT)
Department of Health and Human Services
$2.5M
MECHANISMS OF ENVIRONMENTAL AND NUCLEAR AND MITOCHONDRIAL MUTAGENESIS
Department of Health and Human Services
$2.5M
DISCOVERY AND OPTIMIZATION OF AML PROGNOSTIC BIOMARKERS
Department of Health and Human Services
$2.5M
HYBRID PLASMA MARKERS THAT COMPLEMENT CT IMAGING FOR EARLY LUNG CANCER DETECTION
Department of Health and Human Services
$2.4M
MICROCHIMERISM AS ALLOIMMUNITY
Department of Health and Human Services
$2.4M
SEATTLE VACCINE TRIALS UNIT
Department of Health and Human Services
$2.4M
THE IMPACT OF PRENATAL EXPOSURE TO PERSISTENT ORGANIC POLLUTANTS ON KINETICS OF IMMUNE RESPONSE TO VACCINES AND SERO-PROTECTION IN INFANTS
Department of Health and Human Services
$2.4M
TELOMERES AND LUNG CANCER INCIDENCE AND SURVIVAL
Department of Health and Human Services
$2.4M
SHWACHMAN-DIAMOND SYNDROME: MOLECULAR PATHOGENESIS
Department of Health and Human Services
$2.4M
EPIGENOMIC PROFILING OF HISTONE TURNOVER KINETICS IN MAMMALIAN CELLS
Department of Health and Human Services
$2.4M
STATISTICAL METHODS FOR COMBINATION HIV PREVENTION APPROACHES
Department of Defense
$2.3M
USE OF SELENIDE TO IMPROVE OUTCOME IN REPERFUSION INJURY
Department of Health and Human Services
$2.3M
IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
Department of Health and Human Services
$2.3M
DISCOVERING TISSUE-SPECIFIC BIOMARKERS OF RADIATION INJURY IN SILAC-LABELED MICE
Department of Health and Human Services
$2.3M
ESTIMATING OVERDIAGNOSIS IN CANCER SCREENING STUDIES
Department of Health and Human Services
$2.2M
NORMAL AND NEOPLASTIC REGULATION OF CYCLIN E
Department of Health and Human Services
$2.2M
SRC FAMILY KINASES AND CELL GROWTH REGULATION
Department of Health and Human Services
$2.2M
DEVELOPMENT OF NOVEL AIDS GENE THERAPY STRATEGIES IN THE MACAQUE SHIV MODEL
Department of Health and Human Services
$2.2M
INVESTIGATING CREBBP AS A TUMOR SUPPRESSOR IN SMALL CELL LUNG CANCER
Department of Health and Human Services
$2.2M
MYC-DEPENDENT LOSS OF SPLICING FIDELITY IN GLIOBLASTOMA MULTIFORME
Department of Health and Human Services
$2.2M
MINIMIZING MASS PANIC WITH SALIVA TESTS FOR RADIATION EXPOSURE
Department of Health and Human Services
$2.2M
GENETIC ANALYSIS OF AIRFLOW OBSTRUCTION AFTER STEM CELL TRANSPLANTATION
Department of Health and Human Services
$2.2M
MECHANISMS OF ORGANELLE DETERIORATION
Department of Health and Human Services
$2.2M
STATINS FOR PREVENTION OF GVHD
Department of Health and Human Services
$2.2M
ALPHA-CATENIN IN REGULATION OF TISSUE HOMEOSTASIS AND CANCER
Department of Health and Human Services
$2.2M
REGULATORY T CELL MODULATION OF IMMUNITY TO MUCOSAL VIRAL INFECTIONS
Department of Health and Human Services
$2.1M
CYTOTOXIC T-CELL RESPONSES TO HSV IN HIV-INFECTED PERSONS
Department of Health and Human Services
$2.1M
T CELL MODULATION BY NKG2D
Department of Health and Human Services
$2.1M
ELUCIDATION OF A BACTERIAL CELL SHAPE GENERATING PROGRAM AND PATHOGENIC FUNCTIONS
Department of Health and Human Services
$2.1M
TILLING THE ZEBRAFISH GENOME: A REVERSE GENETIC APPROACH
Department of Health and Human Services
$2.1M
ADOPTIVE T CELL THERAPY OF MELANOMA TARGETING NY-ESO-1
Department of Health and Human Services
$2.1M
MECHANISMS OF TANGENTIAL NEURON MIGRATION
Department of Health and Human Services
$2.1M
DYNAMICS OF GRADIENT SENSING IN SINGLE CELLS
Department of Health and Human Services
$2.1M
"NEUTROPHIL ELASTASE LINKS IDIOPATHIC PULMONARY FIBROSIS AND LUNG CANCER"
Department of Health and Human Services
$2M
DISSECTING THE MECHANISM OF INCREASED GENOMIC INSTABILITY IN AGING YEAST
Department of Health and Human Services
$2M
POPULATION PHARMACOKINETICS/PHARMACODYNAMICS IN NONABLATIVE STEM CELL RECIPIENTS
Department of Health and Human Services
$2M
NOVEL CULTIVATION METHODS FOR THE DOMESTICATION OF VAGINAL BACTERIA
Department of Health and Human Services
$2M
FFPE VALIDATION OF A SURVIVAL GENE SIGNATURE IN HPV-NEGATIVE ORAL CAVITY CANCER
Department of Health and Human Services
$2M
NORMAL AND CANCER STEM CELLS OF THE MAMMARY GLAND
Department of Health and Human Services
$2M
INTERROGATION OF MLL2 AS A TUMOR SUPPRESSOR GENE IN LUNG CANCER
Department of Health and Human Services
$2M
HIGH-PERFORMANCE COMPUTE CLUSTER FOR COMPREHENSIVE CANCER AND INFECTIOUS DISEASES RESEARCH
Department of Health and Human Services
$2M
IRS-1 REGULATES INFLAMMATORY CELL RECRUITMENT IN LUNG CANCER
Department of Health and Human Services
$2M
CHEMOPROTECTION AGAINST AMINOGLYCOSIDE-INDUCED OTOTOXICITY
Department of Health and Human Services
$2M
PREVENTING TUMOR RELAPSE WITH BIOMATERIAL-SUPPORTED LYMPHOCYTE IMPLANTS
Department of Health and Human Services
$1.9M
CELL-STRESS INDUCED IMMUNE RESPONSES
Department of Health and Human Services
$1.9M
USING GENETICALLY ENGINEERED MOUSE MODELS OF BRAIN TUMORS TO DEVELOP THERAPEUTIC NANOPARTICLES & BIOMATERIALS
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Source: IRS e-Filed Form 990
No officer or director compensation data available for this organization.
This data is sourced from IRS Form 990, Part VII. It may not be available if the organization files Form 990-N (e-Postcard) or has not yet been enriched.
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Not confirmed
WarningTax-exempt status was revoked on November 15, 2025
Status has NOT been reinstated
Exemption type: 03
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2020 | $630.5M | $513.8M | $646M | $1.5B | $797.3M |
| 2019 | $698.1M | $506.6M | $633.7M | $1.3B | $826.9M |
| 2018 | $851.2M | $498.1M | $588.1M | $1.2B | $731.2M |
| 2017 | $550.3M | $444.9M | $523M | $978.7M |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
Financial data: IRS Form 990 via ProPublica Nonprofit Explorer (Tax Year 2020)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File · ProPublica Nonprofit Explorer
Revocation status: IRS Auto-Revocation List
| $497.6M |
| 2016 | $598.7M | $392.2M | $481.1M | $954.4M | $484.6M |
| 2015 | $485.9M | $370.8M | $433.2M | $950.1M | $491.8M |
| 2014 | $436.6M | $352.6M | $413.9M | $735.2M | $283.2M |
| 2013 | $413.4M | $348.4M | $427.8M | $698.6M | $235.7M |
| 2012 | $442.4M | $369.2M | $436.2M | $714.1M | $232.9M |
| 2011 | $470.6M | $388.5M | $426.2M | $714.1M | $253M |
| 990 |
Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990 | Data |
| 2014 | 990 | Data |
| 2013 | 990 | Data |
| 2012 | 990 | Data |
| 2011 | 990 | Data |
| 2010 | 990 | — |
| 2009 | 990 | — |
| 2008 | 990 | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2003 | 990 | — |
| 2002 | 990 | — |
| 2001 | 990 | — |